ENZON PHARMACEUTICALS INC - stock earnings
ENZN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 321000 USD | ? USD |
| 2023Q2 | 183000 USD | ? USD |
| 2023Q1 | 197000 USD | ? USD |
| 2022Q4 | 333000 USD | 26000 USD |
| 2022Q3 | -15000 USD | ? USD |
| 2022Q2 | -213000 USD | ? USD |
| 2022Q1 | -291000 USD | ? USD |
| 2021Q4 | -235000 USD | 29000 USD |
| 2021Q3 | -226000 USD | ? USD |
| 2021Q2 | -19000 USD | 291000 USD |
| 2021Q1 | 11000 USD | 381000 USD |
| 2020Q4 | -426000 USD | 34000 USD |
| 2020Q3 | -407000 USD | 8000 USD |
| 2020Q2 | -236000 USD | 8000 USD |
| 2020Q1 | -242000 USD | 2000 USD |
| 2019Q4 | -262000 USD | 49000 USD |
| 2019Q3 | -325000 USD | 2000 USD |
| 2019Q2 | -21000 USD | 207000 USD |
| 2019Q1 | -371000 USD | -51000 USD |
| 2018Q4 | 6.9 million USD | 7.1 million USD |
| 2018Q3 | -520000 USD | -280000 USD |
| 2018Q2 | -206000 USD | 61000 USD |
| 2018Q1 | -312000 USD | 15000 USD |
| 2017Q4 | 462000 USD | 13000 USD |
| 2017Q3 | 153000 USD | 151000 USD |
| 2017Q2 | 4.2 million USD | 6.8 million USD |
| 2017Q1 | 645000 USD | 1.4 million USD |
| 2016Q4 | -4.6 million USD | 853000 USD |
| 2016Q3 | 936000 USD | 2.0 million USD |
| 2016Q2 | 1.0 million USD | 2.3 million USD |
| 2016Q1 | 1.5 million USD | 3.3 million USD |
| 2015Q4 | 12.5 million USD | 3.2 million USD |
| 2015Q3 | -1.8 million USD | 3.8 million USD |
| 2015Q2 | 3.8 million USD | 5.2 million USD |
| 2015Q1 | 7.2 million USD | 5.3 million USD |
| 2014Q4 | 5.8 million USD | 6.3 million USD |
| 2014Q3 | 7.6 million USD | 8.2 million USD |
| 2014Q2 | 6.9 million USD | 7.8 million USD |
| 2014Q1 | 8.5 million USD | 9.0 million USD |
| 2013Q4 | 5.5 million USD | 7.4 million USD |
| 2013Q3 | 5.6 million USD | 8.8 million USD |
| 2013Q2 | 4.7 million USD | 8.1 million USD |
| 2013Q1 | 2.4 million USD | 10.2 million USD |
| 2012Q4 | -5.2 million USD | 10.6 million USD |
| 2012Q3 | 4.2 million USD | 11.1 million USD |
| 2012Q2 | -729000 USD | 10.2 million USD |
| 2012Q1 | -1.1 million USD | 10.6 million USD |
| 2011Q4 | ? USD | 10.0 million USD |
| 2011Q3 | -9.1 million USD | 10.4 million USD |
| 2011Q2 | -7.1 million USD | 9.6 million USD |
| 2011Q1 | 431000 USD | 18.0 million USD |
| 2010Q4 | ? USD | 12.5 million USD |
| 2010Q3 | ? USD | 13.5 million USD |
| 2010Q2 | ? USD | 13.7 million USD |
| 2010Q1 | 199.8 million USD | 17.3 million USD |
| 2009Q4 | ? USD | 12.2 million USD |
| 2009Q3 | 133000 USD | 13.0 million USD |
| 2009Q2 | ? USD | 13.2 million USD |
| 2009Q1 | 6.2 million USD | 13.1 million USD |
| 2008Q4 | ? USD | 48.4 million USD |
| 2008Q3 | ? USD | 48.8 million USD |
| 2008Q2 | ? USD | 51.0 million USD |
| 2008Q1 | 1.5 million USD | 48.8 million USD |
| 2007Q4 | 268000 USD | 48.1 million USD |
| 2007Q3 | 87.5 million USD | 46.8 million USD |
| 2007Q2 | ? USD | 49.2 million USD |
| 2007Q1 | ? USD | 41.5 million USD |
| 2006Q4 | ? USD | 47.5 million USD |
| 2006Q3 | 2.2 million USD | 45.9 million USD |
| 2006Q2 | 11.0 million USD | 47.6 million USD |
| 2006Q1 | 21.7 million USD | 44.7 million USD |
| 2005Q2 | ? USD | 43.7 million USD |
| 2005Q1 | ? USD | 39.2 million USD |
| 2004Q4 | ? USD | 42.9 million USD |
| 2004Q3 | ? USD | 40.5 million USD |
| 2004Q2 | ? USD | 42.9 million USD |
| 2004Q1 | 8.1 million USD | 44.4 million USD |
| 2003Q4 | ? USD | 41.7 million USD |
| 2003Q3 | 1.1 million USD | 40.6 million USD |
| 2003Q2 | 40.6 million USD | 46.7 million USD |
| 2003Q1 | 7.6 million USD | 43.2 million USD |
| 2002Q4 | ? USD | 31.5 million USD |
| 2002Q3 | 12.8 million USD | 25.1 million USD |
| 2002Q2 | 20.8 million USD | 25.2 million USD |
| 2002Q1 | 12.2 million USD | 19.8 million USD |
| 2001Q4 | 8.6 million USD | 18.6 million USD |
| 2001Q3 | 4.2 million USD | 12.1 million USD |
| 2001Q2 | 3.3 million USD | 10.5 million USD |
| 2001Q1 | 5.5 million USD | 9.9 million USD |
| 2000Q4 | 2.1 million USD | 6.0 million USD |
| 2000Q3 | 572000 USD | 5.2 million USD |
| 2000Q2 | ? USD | 4.6 million USD |
| 2000Q1 | ? USD | 5.7 million USD |
ENZN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.0 million USD | 26000 USD |
| 2022 | -186000 USD | 26000 USD |
| 2021 | -469000 USD | 701000 USD |
| 2020 | -1.3 million USD | 52000 USD |
| 2019 | -979000 USD | 207000 USD |
| 2018 | 5.8 million USD | 6.9 million USD |
| 2017 | 5.4 million USD | 8.4 million USD |
| 2016 | -1.1 million USD | 8.4 million USD |
| 2015 | 21.6 million USD | 17.5 million USD |
| 2014 | 28.8 million USD | 31.2 million USD |
| 2013 | 18.2 million USD | 34.5 million USD |
| 2012 | -2.8 million USD | 42.6 million USD |
| 2011 | -20.8 million USD | 48.1 million USD |
| 2010 | 177.2 million USD | 57.0 million USD |
| 2009 | 683000 USD | 184.6 million USD |
| 2008 | ? USD | 196.9 million USD |
| 2007 | 83.1 million USD | 185.6 million USD |
| 2006 | 21.3 million USD | 185.7 million USD |
| 2004 | ? USD | 166.3 million USD |
| 2003 | 4.2 million USD | 169.6 million USD |
| 2002 | 45.7 million USD | 146.4 million USD |
| 2001 | 45.8 million USD | 75.8 million USD |
| 2000 | 11.5 million USD | 31.6 million USD |
| 1999 | ? USD | 17.0 million USD |
ENZN
Price: $0.08
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -9
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 5587
Market Capitalization: 5.6 million
Average Dividend Frequency: 1